1. Home
  2. PYPD vs ISPR Comparison

PYPD vs ISPR Comparison

Compare PYPD & ISPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PolyPid Ltd.

PYPD

PolyPid Ltd.

N/A

Current Price

$6.55

Market Cap

107.0M

Sector

Health Care

ML Signal

N/A

Logo Ispire Technology Inc.

ISPR

Ispire Technology Inc.

N/A

Current Price

$1.53

Market Cap

89.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PYPD
ISPR
Founded
2008
2010
Country
Israel
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Medicinal Chemicals and Botanical Products
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
107.0M
89.5M
IPO Year
2014
2023

Fundamental Metrics

Financial Performance
Metric
PYPD
ISPR
Price
$6.55
$1.53
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
2
Target Price
★ $11.50
$4.70
AVG Volume (30 Days)
★ 193.8K
12.9K
Earning Date
11-11-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 15.94
EPS
★ N/A
N/A
Revenue
N/A
★ $96,014,610.00
Revenue This Year
N/A
$12.14
Revenue Next Year
N/A
$14.77
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$3.50
$1.01
52 Week High
$7.15
$3.87

Technical Indicators

Market Signals
Indicator
PYPD
ISPR
Relative Strength Index (RSI) 66.97 46.35
Support Level $4.26 $1.23
Resistance Level $7.15 $1.65
Average True Range (ATR) 0.52 0.17
MACD 0.05 -0.01
Stochastic Oscillator 64.65 25.00

Price Performance

Historical Comparison
PYPD
ISPR

About PYPD PolyPid Ltd.

PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. The company's product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.

About ISPR Ispire Technology Inc.

Ispire Technology Inc is engaged in the research and development, design, commercialization, sales, marketing, and distribution of branded and non-branded vaping hardware products in both the nicotine and cannabis spaces, as well as the assembly of nicotine pouch products and other next-generation nicotine products. The company sells its e-cigarette and pouch products globally, in markets where it is legally permitted to do so. The majority of its nicotine products are marketed under the Aspire brand name, and the cannabis products are marketed under the Ispire brand name. Geographically, the company generates the majority of its revenue from Europe, followed by North America, Asia Pacific, and other markets.

Share on Social Networks: